▁Introduction 10.375
: 6.5078125
<0x0A> 4.01953125
P 4.65234375
ark 4.5703125
inson 2.837890625
' 0.296875
s 0.0029354095458984375
▁D 1.4013671875
ise 0.0040435791015625
ase 0.004608154296875
▁( 1.7998046875
PD 0.0787353515625
) 0.165771484375
▁is 0.31103515625
▁a 0.52685546875
▁progress 1.45703125
ive 0.0211639404296875
▁ne 0.471923828125
uro 0.00014841556549072266
de 0.30078125
gener 0.003849029541015625
ative 0.004795074462890625
▁dis 0.81005859375
order 0.004291534423828125
▁associated 3.892578125
▁with 0.0219879150390625
▁motor 2.58984375
▁sympt 1.2421875
oms 0.00890350341796875
, 1.4912109375
▁including 2.013671875
▁trem 1.0029296875
ors 2.404296875
, 0.299560546875
▁rig 0.66796875
id 0.0019330978393554688
ity 0.01163482666015625
, 0.147705078125
▁br 1.5986328125
ady 0.00396728515625
k 0.00899505615234375
ines 0.0016012191772460938
ia 0.00534820556640625
, 0.2054443359375
▁and 0.291748046875
▁post 0.58154296875
ural 0.03155517578125
▁inst 0.0775146484375
ability 0.00199127197265625
. 0.40234375
▁While 5.71484375
▁medic 6.09375
ation 1.310546875
▁and 1.0126953125
▁re 3.447265625
h 0.0162200927734375
abil 1.1563301086425781e-05
itation 0.08013916015625
▁ther 1.74609375
ap 0.38232421875
ies 0.0002009868621826172
▁are 1.30078125
▁commonly 4.03515625
▁employed 2.193359375
▁to 0.85302734375
▁manage 1.5048828125
▁P 2.103515625
D 0.00040650367736816406
, 1.513671875
▁increasing 7.40625
▁evidence 0.74267578125
▁suggests 0.54736328125
▁that 0.1787109375
▁physical 3.283203125
▁exercise 2.01953125
, 2.95703125
▁such 3.390625
▁as 0.0027008056640625
▁b 5.765625
icy 0.330810546875
cle 2.365234375
▁exercise 2.154296875
, 0.416259765625
▁can 1.36328125
▁contribute 4.47265625
▁significantly 4.29296875
▁to 0.0579833984375
▁the 0.98193359375
▁overall 3.111328125
▁well 2.328125
- 0.257568359375
be 0.0017805099487304688
ing 7.712841033935547e-05
▁and 1.625
▁sympt 5.68359375
om 0.03253173828125
▁management 0.8408203125
▁of 0.1527099609375
▁individuals 1.8349609375
▁diagn 3.96875
osed 0.00024306774139404297
▁with 0.00923919677734375
▁P 0.10382080078125
D 0.0003752708435058594
. 0.1529541015625
▁This 2.552734375
▁ess 7.14453125
ay 0.0026187896728515625
▁a 2.677734375
ims 0.0006117820739746094
▁to 0.02581787109375
▁evaluate 4.51953125
▁the 0.26513671875
▁effect 2.92578125
iveness 0.685546875
▁of 0.126220703125
▁b 1.291015625
icy 0.0050811767578125
cle 0.052276611328125
▁exercise 0.0775146484375
▁as 1.951171875
▁a 0.274658203125
▁form 3.431640625
▁of 0.00514984130859375
▁physical 0.9541015625
▁activity 1.1083984375
▁in 1.3876953125
▁impro 2.669921875
ving 7.069110870361328e-05
▁the 1.0234375
▁stability 8.8359375
▁and 0.8330078125
▁physical 4.76953125
▁health 2.814453125
▁of 0.07989501953125
▁P 3.271484375
D 0.0029449462890625
▁patients 0.19189453125
, 2.123046875
▁with 2.46484375
▁a 0.7021484375
▁specific 2.12890625
▁focus 0.186767578125
▁on 0.01285552978515625
▁the 1.087890625
▁study 5.9609375
▁conducted 4.01953125
▁by 0.148681640625
▁T 4.77734375
ii 7.93359375
h 0.2357177734375
onen 0.01873779296875
▁et 0.45263671875
▁al 0.0188751220703125
. 0.219970703125
▁( 0.60107421875
2 0.08819580078125
0 0.0067291259765625
2 2.587890625
1 1.1240234375
). 0.44970703125
<0x0A> 0.5869140625
Body 7.51953125
: 5.50390625
<0x0A> 2.228515625
1 4.59375
. 0.316650390625
▁Study 5.90234375
▁Over 4.015625
view 0.0169830322265625
: 1.841796875
<0x0A> 0.1275634765625
T 2.734375
ii 0.55029296875
h 0.0010728836059570312
onen 0.0013685226440429688
▁et 0.386474609375
▁al 0.0095062255859375
. 0.10345458984375
▁( 0.181396484375
2 0.004192352294921875
0 0.00035309791564941406
2 0.0039825439453125
1 0.00457000732421875
) 0.059051513671875
▁conducted 1.1982421875
▁a 0.23291015625
▁random 1.046875
ized 0.0267333984375
▁controlled 0.65869140625
▁trial 0.254150390625
▁to 1.361328125
▁investigate 2.32421875
▁the 0.10699462890625
▁impact 3.482421875
▁of 0.06414794921875
▁b 0.8134765625
icy 0.007007598876953125
cle 0.04058837890625
▁exercise 0.09210205078125
▁on 0.343994140625
▁P 3.38671875
D 0.0037059783935546875
▁sympt 1.6533203125
oms 0.2196044921875
▁and 1.638671875
▁overall 3.93359375
▁well 1.1279296875
- 0.07464599609375
be 0.00047588348388671875
ing 5.555152893066406e-05
. 0.84033203125
▁The 0.95068359375
▁study 1.03125
▁involved 2.18359375
▁ 0.3564453125
1 1.2490234375
3 2.517578125
0 1.794921875
▁participants 1.6513671875
▁diagn 1.697265625
osed 0.00021588802337646484
▁with 0.010986328125
▁P 0.09674072265625
D 0.0007877349853515625
, 1.2041015625
▁who 1.82421875
▁were 0.2188720703125
▁assigned 2.126953125
▁to 0.480712890625
▁either 0.82568359375
▁an 2.48046875
▁exercise 0.17041015625
▁group 0.650390625
▁performing 8.6953125
▁b 0.6103515625
icy 0.0040435791015625
cle 0.029754638671875
▁exercise 0.1649169921875
▁or 1.58203125
▁a 0.362060546875
▁control 0.15869140625
▁group 0.0102386474609375
▁receiving 2.5
▁usual 2.212890625
▁care 0.33837890625
▁for 3.4765625
▁a 3.44921875
▁period 0.92041015625
▁of 0.005062103271484375
▁six 2.7109375
▁months 0.1513671875
. 0.08673095703125
▁Primary 6.01953125
▁out 0.6787109375
comes 0.00016689300537109375
▁included 1.107421875
▁balance 5.33203125
, 0.76513671875
▁motor 4.25390625
▁sympt 1.56640625
oms 0.03582763671875
, 0.08935546875
▁quality 2.798828125
▁of 0.0263214111328125
▁life 0.0052032470703125
, 0.1455078125
▁and 0.38427734375
▁overall 2.681640625
▁physical 3.18359375
▁health 0.546875
. 0.349365234375
<0x0A> 1.4375
2 0.76806640625
. 0.004825592041015625
▁Effect 6.09375
▁on 2.96875
▁St 4.22265625
ability 0.017791748046875
: 0.457763671875
<0x0A> 0.00972747802734375
The 1.25390625
▁study 1.6826171875
▁demonstrated 2.70703125
▁that 0.578125
▁b 1.478515625
icy 0.002349853515625
cle 0.0146484375
▁exercise 0.021026611328125
▁had 2.5546875
▁a 0.247314453125
▁positive 1.2421875
▁effect 0.97705078125
▁on 0.02374267578125
▁the 1.568359375
▁stability 0.75048828125
▁of 0.50048828125
▁individuals 2.8359375
▁with 1.798828125
▁P 0.0214080810546875
D 0.00035572052001953125
. 1.1455078125
▁The 1.671875
▁exercise 3.484375
▁group 0.19970703125
▁showed 1.759765625
▁significant 2.24609375
▁improvements 0.267578125
▁in 0.0806884765625
▁static 5.796875
▁and 3.06640625
▁dynamic 0.0966796875
▁balance 0.0897216796875
▁compared 1.7451171875
▁to 0.1453857421875
▁the 0.0467529296875
▁control 0.0273590087890625
▁group 0.006488800048828125
. 0.7490234375
▁En 10.0859375
hanced 0.11346435546875
▁stability 2.376953125
▁can 3.90234375
▁reduce 3.515625
▁the 0.222412109375
▁risk 0.370849609375
▁of 0.039520263671875
▁falls 0.2254638671875
▁and 0.67822265625
▁associated 4.17578125
▁inj 0.403564453125
uries 0.0006279945373535156
, 0.6474609375
▁thereby 3.0078125
▁impro 0.444580078125
ving 1.609325408935547e-05
▁the 1.400390625
▁overall 0.377685546875
▁safety 6.1328125
▁and 0.58154296875
▁quality 0.93505859375
▁of 0.00951385498046875
▁life 0.009429931640625
▁for 1.4287109375
▁P 1.98046875
D 0.00045943260192871094
▁patients 0.042236328125
. 0.06439208984375
<0x0A> 0.2998046875
3 0.35595703125
. 0.0015096664428710938
▁Effect 0.147705078125
▁on 0.017578125
▁Phys 1.4541015625
ical 0.003665924072265625
▁Health 0.08148193359375
: 0.0207061767578125
<0x0A> 0.0008540153503417969
B 2.056640625
icy 0.38916015625
cle 0.00475311279296875
▁exercise 0.00605010986328125
▁also 1.916015625
▁yield 7.59765625
ed 0.0004596710205078125
▁notable 5.109375
▁improvements 0.5126953125
▁in 0.03765869140625
▁the 2.275390625
▁physical 0.33056640625
▁health 0.0266876220703125
▁of 0.09295654296875
▁P 0.88330078125
D 0.00022864341735839844
▁patients 0.049468994140625
. 0.2044677734375
▁The 0.73046875
▁exercise 0.217041015625
▁group 0.006702423095703125
▁exhib 3.375
ited 0.0004334449768066406
▁increased 3.5
▁aer 3.1171875
ob 0.00048828125
ic 0.0011920928955078125
▁capacity 1.27734375
, 0.94580078125
▁mus 1.9970703125
cular 1.412109375
▁strength 0.258056640625
, 0.1075439453125
▁and 0.261962890625
▁flex 2.365234375
ibility 0.0005278587341308594
▁compared 0.5966796875
▁to 0.0163116455078125
▁the 0.0245819091796875
▁control 0.00884246826171875
▁group 0.0032939910888671875
. 0.1444091796875
▁These 0.978515625
▁improvements 0.509765625
▁are 2.556640625
▁cru 4.484375
cial 0.001190185546875
, 4.90625
▁as 0.10113525390625
▁P 2.99609375
D 0.00054168701171875
▁often 4.3046875
▁leads 1.1943359375
▁to 0.0010852813720703125
▁decre 2.80859375
ased 0.050811767578125
▁physical 0.841796875
▁capabilities 5.12890625
▁and 0.95654296875
▁mus 3.19140625
cle 0.37353515625
▁weak 1.5185546875
ness 0.002155303955078125
. 1.1083984375
▁The 2.103515625
▁benefits 4.33203125
▁gained 6.53515625
▁from 0.28076171875
▁b 1.0712890625
icy 0.001865386962890625
cle 0.0077972412109375
▁exercise 0.0087738037109375
▁can 0.61474609375
▁help 1.71875
▁individuals 1.7763671875
▁maintain 1.9208984375
▁independent 6.33984375
▁daily 5.5703125
▁activities 1.2158203125
▁and 0.89990234375
▁mit 7.3671875
ig 8.821487426757812e-06
ate 0.0014982223510742188
▁the 0.339111328125
▁overall 5.4765625
▁decl 3.181640625
ine 0.0029430389404296875
▁in 0.2017822265625
▁physical 0.295654296875
▁function 1.75
▁caused 3.931640625
▁by 0.0005698204040527344
▁the 2.404296875
▁disease 0.25341796875
. 0.03424072265625
<0x0A> 0.064697265625
4 0.626953125
. 0.0016078948974609375
▁Imp 3.275390625
act 0.73681640625
▁on 0.0662841796875
▁P 4.78125
D 0.0221710205078125
▁Sym 0.26611328125
pt 3.457069396972656e-05
oms 0.01303863525390625
: 0.08447265625
<0x0A> 0.0008802413940429688
In 3.3125
▁addition 0.75439453125
▁to 0.056884765625
▁stability 6.76171875
▁and 0.1328125
▁physical 0.2254638671875
▁health 0.0472412109375
, 0.43408203125
▁b 0.300537109375
icy 0.0003151893615722656
cle 0.0014753341674804688
▁exercise 0.001224517822265625
▁showed 5.109375
▁prom 2.59375
ising 0.0015115737915039062
▁effects 1.2138671875
▁on 0.097412109375
▁P 0.640625
D 0.00016129016876220703
▁sympt 0.01502227783203125
oms 0.023284912109375
. 0.379150390625
▁The 0.32275390625
▁exercise 0.2027587890625
▁group 0.0028514862060546875
▁experienced 2.689453125
▁a 1.2880859375
▁reduction 2.158203125
▁in 0.01091766357421875
▁motor 1.7265625
▁sympt 0.08526611328125
oms 0.012939453125
▁such 1.8896484375
▁as 0.0010347366333007812
▁br 2.75390625
ady 0.0013513565063476562
k 0.0008907318115234375
ines 0.0010623931884765625
ia 0.00211334228515625
▁and 1.05859375
▁rig 0.8125
id 0.00046181678771972656
ity 0.00035309791564941406
▁compared 0.923828125
▁to 0.0101776123046875
▁the 0.0145416259765625
▁control 0.0066986083984375
▁group 0.0019016265869140625
, 2.8984375
▁potentially 4.77734375
▁due 2.5703125
▁to 0.003925323486328125
▁the 0.92041015625
▁increase 2.962890625
▁in 0.0130767822265625
▁dop 6.77734375
am 0.0015573501586914062
ine 0.446533203125
▁release 3.845703125
▁associated 2.40234375
▁with 0.0008106231689453125
▁exercise 0.416015625
. 0.089599609375
▁Ex 5.296875
erc 0.04351806640625
ise 0.000125885009765625
▁has 1.7900390625
▁been 0.8525390625
▁shown 0.308837890625
▁to 0.0100555419921875
▁posit 4.0390625
ively 6.282329559326172e-05
▁mod 3.9453125
ulate 0.0008249282836914062
▁the 0.89501953125
▁dop 2.646484375
am 0.00023472309112548828
iner 1.064453125
g 0.0001100301742553711
ic 4.6372413635253906e-05
▁system 0.26025390625
, 0.623046875
▁which 0.55810546875
▁is 1.1484375
▁significantly 7.6328125
▁affected 2.603515625
▁by 0.7998046875
▁P 0.291259765625
D 0.00038814544677734375
, 2.41015625
▁leading 2.267578125
▁to 0.001983642578125
▁sympt 3.396484375
om 0.06597900390625
atic 1.2314453125
▁relief 1.4833984375
. 0.48193359375
<0x0A> 0.366455078125
5 0.449951171875
. 0.0011720657348632812
▁Over 3.091796875
all 0.043487548828125
▁Well 1.7353515625
- 0.08135986328125
be 1.2685546875
ing 9.179115295410156e-06
: 0.0450439453125
<0x0A> 0.0007672309875488281
The 1.4619140625
▁study 1.12890625
▁conducted 5.59765625
▁by 0.0261688232421875
▁T 0.0095367431640625
ii 0.0016803741455078125
h 0.00031828880310058594
onen 0.0005936622619628906
▁et 0.00988006591796875
▁al 0.0017232894897460938
. 0.017181396484375
▁( 0.0269622802734375
2 0.0002415180206298828
0 4.184246063232422e-05
2 0.00045871734619140625
1 0.0016202926635742188
) 0.0136260986328125
▁demonstrated 1.6650390625
▁that 0.2919921875
▁b 0.346923828125
icy 0.0003974437713623047
cle 0.001819610595703125
▁exercise 0.0012292861938476562
▁posit 3.52734375
ively 0.00011599063873291016
▁impact 0.27734375
ed 0.3974609375
▁the 0.92919921875
▁overall 0.18798828125
▁well 0.098876953125
- 0.01239013671875
be 0.0002206563949584961
ing 2.8371810913085938e-05
▁of 0.04522705078125
▁individuals 0.88525390625
▁with 1.0263671875
▁P 0.0128326416015625
D 0.00017845630645751953
. 0.1064453125
▁The 0.324951171875
▁exercise 0.35205078125
▁group 0.004833221435546875
▁reported 1.28125
▁better 5.08984375
▁quality 1.712890625
▁of 0.014312744140625
▁life 0.01398468017578125
▁and 1.5576171875
▁reduced 3.388671875
▁de 2.423828125
press 1.0166015625
ive 0.0011587142944335938
▁sympt 0.057647705078125
oms 0.007404327392578125
▁compared 0.19677734375
▁to 0.010650634765625
▁the 0.018585205078125
▁control 0.00485992431640625
▁group 0.0016450881958007812
. 0.1407470703125
▁These 1.2783203125
▁psych 6.5625
ological 0.27783203125
▁benefits 0.2041015625
▁are 1.509765625
▁vital 4.78515625
▁as 3.041015625
▁P 0.55224609375
D 0.00013113021850585938
▁often 0.83984375
▁presents 4.98828125
▁with 0.2481689453125
▁com 8.0390625
orb 0.00014460086822509766
id 0.0007791519165039062
▁mental 2.541015625
▁health 0.152099609375
▁challeng 3.27734375
es 1.7881393432617188e-06
▁and 2.96875
▁decre 3.2890625
ased 0.0256805419921875
▁well 2.796875
- 0.022308349609375
be 0.0002529621124267578
ing 1.2516975402832031e-05
. 0.389892578125
<0x0A> 1.0849609375
Con 3.01953125
clusion 0.30517578125
: 0.30078125
<0x0A> 3.3359375
In 2.44140625
▁conclusion 0.51953125
, 0.0014362335205078125
▁the 0.9638671875
▁study 0.5009765625
▁conducted 0.2108154296875
▁by 0.001220703125
▁T 0.0032596588134765625
ii 0.0011806488037109375
h 0.0006947517395019531
onen 0.0003466606140136719
▁et 0.0026092529296875
▁al 0.0007748603820800781
. 0.0100860595703125
▁( 0.00864410400390625
2 0.0003044605255126953
0 1.4066696166992188e-05
2 0.00043511390686035156
1 0.0015268325805664062
) 0.00560760498046875
▁provides 4.6015625
▁comp 1.6923828125
elling 0.0001684427261352539
▁evidence 0.0218353271484375
▁supporting 3.3203125
▁the 0.07745361328125
▁effect 1.5654296875
iveness 0.0234375
▁of 0.025238037109375
▁b 0.140869140625
icy 0.0005588531494140625
cle 0.0019817352294921875
▁exercise 0.0022106170654296875
▁as 0.630859375
▁an 1.9150390625
▁inter 2.763671875
vention 0.0019626617431640625
▁for 0.5595703125
▁individuals 1.1884765625
▁diagn 0.358154296875
osed 6.604194641113281e-05
▁with 0.0011577606201171875
▁Park 1.7470703125
inson 0.0002269744873046875
' 0.0046539306640625
s 4.887580871582031e-05
▁D 0.60107421875
ise 2.872943878173828e-05
ase 0.0001304149627685547
. 0.07794189453125
▁The 0.427490234375
▁results 2.275390625
▁indicate 2.439453125
▁significant 3.732421875
▁improvements 0.1773681640625
▁in 0.0092926025390625
▁stability 2.470703125
, 0.238525390625
▁physical 0.263916015625
▁health 0.05572509765625
, 0.0140380859375
▁P 6.125
D 0.00034737586975097656
▁sympt 0.0230560302734375
oms 0.111328125
, 0.03631591796875
▁and 0.2080078125
▁overall 0.03265380859375
▁well 0.0355224609375
- 0.0101318359375
be 0.0001552104949951172
ing 2.849102020263672e-05
. 0.7978515625
▁In 3.79296875
cor 4.25390625
por 0.00032210350036621094
ating 0.09332275390625
▁b 0.603515625
icy 0.0011119842529296875
cle 0.017333984375
▁exercise 0.01059722900390625
▁as 1.52734375
▁part 0.767578125
▁of 0.00016224384307861328
▁the 2.658203125
▁usual 5.8984375
▁care 0.8369140625
▁for 1.43359375
▁P 0.93212890625
D 0.00036144256591796875
▁patients 0.1300048828125
▁can 0.475341796875
▁be 3.30859375
▁a 1.4267578125
▁valuable 1.5439453125
▁and 2.267578125
▁accessible 4.13671875
▁inter 1.3740234375
vention 0.0003116130828857422
▁to 1.74609375
▁enh 3.83984375
ance 0.00010347366333007812
▁their 3.583984375
▁quality 0.8896484375
▁of 0.00390625
▁life 0.0014858245849609375
. 0.62744140625
▁Further 3.45703125
▁research 0.4248046875
▁and 4.84765625
▁larger 3.369140625
- 1.06640625
scale 0.02252197265625
▁studies 0.55712890625
▁are 0.116943359375
▁war 1.6552734375
r 0.00038909912109375
anted 9.036064147949219e-05
▁to 0.059051513671875
▁confirm 1.7783203125
▁the 0.8193359375
▁find 1.6845703125
ings 7.152557373046875e-07
▁and 1.1513671875
▁identify 2.4921875
▁optimal 3.263671875
▁exercise 0.7138671875
▁protocol 1.88671875
s 0.0134124755859375
▁for 1.0205078125
▁different 5.6171875
▁stages 4.05078125
▁of 0.0772705078125
▁P 0.615234375
D 0.00017976760864257812
. 0.54931640625
▁Non 7.79296875
eth 0.006671905517578125
eless 1.4781951904296875e-05
, 0.0009765625
▁these 3.0859375
▁find 0.73046875
ings 2.384185791015625e-07
▁highlight 2.84765625
▁the 0.0687255859375
▁potential 1.3359375
▁of 0.481689453125
▁b 0.429443359375
icy 0.00083160400390625
cle 0.0110015869140625
▁exercise 0.004791259765625
▁as 0.2047119140625
▁a 0.435302734375
▁benef 4.0078125
icial 0.00022268295288085938
▁physical 3.751953125
▁activity 0.23193359375
▁for 0.79150390625
▁individuals 0.470458984375
▁living 2.888671875
▁with 0.00048470497131347656
▁Park 2.11328125
inson 0.0004520416259765625
' 0.0018482208251953125
s 0.0008859634399414062
▁D 0.312255859375
ise 8.58306884765625e-06
ase 0.0001633167266845703
. 0.20947265625
